TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants
Status:
Completed
Trial end date:
2017-09-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of
TAK-653 when administered as single and multiple oral doses at escalating dose levels in
healthy participants.